No effect of norepinephrine dose on anti-Xa activity in critically ill patients
.
Sign Up to like & getrecommendations! Published in 2020 at "International journal of clinical pharmacology and therapeutics"
DOI: 10.5414/cp203640
Abstract: OBJECTIVE Low-molecular-weight heparins are frequently used to prevent venous thromboembolism. Vasopressor therapy may be associated with inadequate anti-factor Xa activity, thereby increasing the risk of venous thromboembolism. We aimed to assess the association between anti-factor… read more here.
Keywords: activity; norepinephrine dose; factor; dose anti ... See more keywords